KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Clinical trial NCT06097793 · UNKNOWN

Trial details

NCT number: NCT06097793
Sponsor: Kousai Bio Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2023-12-04
Primary completion: 2024-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.